Yankees Score with ...
Health Care: Drugs
Cleveland BioLabs Inc. (CBLI: NASDAQ)
$1.66 0.02 | 1.22%
05/24/13 - 03:59 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 1.66 |
| 52 Week High | 2.95 |
| 52 Week Low | 1.23 |
| Avg. Daily Vol. (Mil) | 0.26 |
| Beta (3 year) | 2.16 |
| Share Related Items | |
| Mkt Cap (Mil) | 74.59 |
| Shares Out (Mil) | 44.93 |
| Float (Mil) | 41.24 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.40 |
| Current Ratio | 1.50 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | n.a. |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 18.61 |
| Price/Book | 0.00 |
| Price/Cash Flow | -2.80 |
| Per Share Data | |
| Earnings | -0.55 |
| Sales | 0.09 |
| Book Value | 0.00 |
| Cash Flow | -0.59 |
| Business Summary | |
|---|---|
| Cleveland BioLabs, Inc. is a drug discovery and development company leveraging its proprietary discoveries around programmed cell death to develop treatments for cancer and protection of normal tissues from radiation and other stresses. | |
| General Information | |
| 73 High Street
Buffalo, NY 14203 |
|
| www.cbiolabs.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 85 | |
| CEO: Dr. Yakov Kogan,PhD | |
| Short Interest | |
| Current Month (Mil) | 2.10 |
| Previous Month (Mil) | 1.68 |
| Short Interest Ratio (Days) | 7.10 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -106.40 |
| Return on Investments | 878.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with CBLI
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Contributor5 Health Care Stocks With U...
- Contributor10 Surging Stocks Most at R...
- UserNEW HOME savings
- UserDan128
- UserJustchattin Portfolio 1
- UserSPQR
Latest CBLI Headlines from TheStreet
- Cleveland BioLabs Strengthens Clinical Development Team 04.08.13 | 10:04 am
- Cleveland BioLabs And Incuron Announce Notice Of Allowance From FDA To Commence Clinical Testing With CBL0137 04.02.13 | 07:04 am
- 5 Stocks Under $10 Triggering Breakouts 03.21.13 | 01:03 pm
- Cleveland BioLabs Reports Fourth Quarter And Fiscal 2012 Financial Results And Development Progress 03.14.13 | 07:03 am
- Cleveland BioLabs To Report Fiscal 2012 Financial Results And Provide Operational Update On March 14 03.08.13 | 09:03 am
- Cleveland BioLabs To Present At 15th Annual BIO CEO And Investor Conference 02.05.13 | 07:02 am
- Cleveland BioLabs To Present At BARDA And NIAID Sponsored Symposium On Development Of Radiation Medical Countermeasures 01.24.13 | 07:01 am
- Cleveland BioLabs Prices $15 Million Public Offering Of Common Stock And Warrants 10.19.12 | 09:10 am
- Cleveland BioLabs Announces Proposed Public Offering Of Common Stock And Warrants 10.18.12 | 04:10 pm
- Cleveland BioLabs Submits Proposal To BARDA For Development Funding For Entolimod(TM) (CBLB502) 10.18.12 | 07:10 am
Press Releases for CBLI
- Cleveland BioLabs To Present At Second Annual Marcum LLP Microcap Conference - PR Newswire 05.22.13 | 08:05 am
- Mintz Levin Represents Cleveland Biolabs, Inc. In $8.4 Million Direct Offering - Business Wire 01.04.11 | 09:01 am
Partner Headlines for CBLI
- Acute Radiation Syndrome, Are We Prepared And Who Is Best Preparing Us? - Seeking Alpha 02.27.13 | 09:02 am
- Five Micro Cap Stocks With Recent Insider Buys - Benzinga 07.06.12 | 05:07 pm
- Morning Market Losers - Benzinga 06.05.12 | 09:06 am
- Morning Market Movers - Benzinga 06.04.12 | 09:06 am
- Ultimate Market Recap: Medtox Makes Good, BofA Holds Out on Shareholders - Wall St. Cheat Sheet 06.04.12 | 07:06 am
- 3 Stocks Illuminating Green on a Red Trading Day - Wall St. Cheat Sheet 06.04.12 | 02:06 am
- Will the Next Apple or Google Be Found Among These Micro Caps? - Seeking Alpha 08.18.11 | 09:08 am
- Rodman & Renshaw Lower Cleveland BioLabs PT to $8 - Benzinga 06.27.11 | 04:06 pm
- Zacks #5 Rank Additions for Monday - Tale of the Tape - Zacks 06.20.11 | 09:06 am
- Future Biotech Superstars - Seeking Alpha 03.30.11 | 09:03 am
